CliffBio
small molecule

LEVONORGESTREL

LEVONORGESTREL

Loss of exclusivity—loss of exclusivity
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVONORGESTREL
Active ingredientLEVONORGESTREL
Strength75MG/IMPLANT
Dosage formIMPLANT
RouteIMPLANTATION
ModalitySmall molecule
FDA approvalAugust 1996
Marketing statusDISCN

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.